Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Faculty Members have conducted research related to the Safety and Immunogenicity of Corenapcin, a Sars-Cov-2 Mrna Vaccine, As a Fourth Heterologous Booster in Healthy Iranian Adults: A Double-Blind, Randomized, Placebo-Controlled, Phase 1 Clinical Trial With a Six-Month Follow-Up
Alireza Biglari
Alireza Biglari

Professor of Genetics

Department Medical Genetics

School of Medicine

Tehran University of Medical Sciences

All Documents
17. Kh Domain Containing 3 Like (Khdc3l) Frame-Shift Mutation Causes Both Recurrent Pregnancy Loss and Hydatidiform Mole, European Journal of Obstetrics and Gynecology and Reproductive Biology (2021)